UBER Uber Technologies reports massive Q4 2025 EPS miss versus estimates yet shares still rise modestly TVACU Texas management details highpotential acquisition targets in its latest quarterly earnings release How Metropolitan MCB is positioning for the next five years 063 20260508 Global Artificial Intelligence Sector Risk Prioritization Regulatory Gaps and LongTerm Economic Implications Aditxt ADTX Q3 2025 Earnings EPS 7315 In Line with Estimates Petrol and Diesel Price Hike Will a 3 Increase Be Enough to Cover OMCs Mounting Losses Valmont Industries VMI Reports Strong Q1 2026 Revenue NA EPS Beats Anthropic to Brief Global Financial Regulators on AI Cyber Vulnerabilities Exposed by Mythos Equity EQR Gained 243 Can It Break 6870 20260518 Texas Roadhouse TXRH Fell 187 Is a Recovery Ahead 20260519 World Leaders Watch Closely as TrumpXi Summit Approaches Global Trade and Geopolitical Stakes Tvardi Therapeutics TVRD Stock Analysis 075 Gain What to Watch 20260518 Vertical Aerospace PreFlight Checks Signal Potential Breakout Bill Ackmans Pershing Square Builds Major Microsoft Stake Betting on AI and Cloud Momentum TrioTech International TRT Q3 2024 Results Meet Expectations Revenue NA SLDE Q1 2026 Earnings Strong EPS Beat of 174 Surprise Stock Slightly Down Bitcoin Drops to 75000 as Cryptocurrency Decouples From Tech Stock Rally Natural Gas Futures Decline as February Weather Forecasts Turn Milder UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Signaling Stronger Economic Ties Trumps Beijing Visit No Escalation Seen as MarketPositive Signal AsiaPacific Markets Climb as Investors Weigh USIran Diplomacy and Oil Price Volatility Microsofts GitHub Gains Users but Faces Outages and Competition in AIPowered Coding Market Fresh Del Monte Produce FDP Rallies 177 Approaches Key Resistance Level Golar LNG Drops 255 as Pressure Builds Key Support at 4797 in Focus Moelis Company MC Holds Steady Near Support Amid Modest Gains Legence Corp LGN Surges 659 as Buyers Test Key Resistance Levels Dermata Therapeutics DRMA Shares Climb 385 as Stock Tests Key Resistance Levels